Document And Entity Information
Document And Entity Information $ in Thousands | 12 Months Ended |
Apr. 30, 2021USD ($)shares | |
Document Information [Line Items] | |
Entity Registrant Name | BIOSYNERGY INC |
Entity Central Index Key | 0000715812 |
Trading Symbol | bsyn |
Current Fiscal Year End Date | --04-30 |
Entity Filer Category | Non-accelerated Filer |
Entity Current Reporting Status | Yes |
Entity Voluntary Filers | No |
Entity Well-known Seasoned Issuer | No |
Entity Emerging Growth Company | false |
Entity Small Business | true |
Entity Interactive Data Current | Yes |
Entity Common Stock, Shares Outstanding (in shares) | shares | 14,935,511 |
Entity Public Float | $ | $ 0 |
Entity Shell Company | false |
Document Type | 10-K |
Document Period End Date | Apr. 30, 2021 |
Document Fiscal Year Focus | 2021 |
Document Fiscal Period Focus | FY |
Amendment Flag | false |
Title of 12(g) Security | Common Stock, No Par Value |
Balance Sheets
Balance Sheets - USD ($) | Apr. 30, 2021 | Apr. 30, 2020 |
Current Assets | ||
Cash | $ 1,250,581 | $ 1,245,282 |
Accounts receivable. Trade (net of allowance for doubtful accounts of $500 in 2021 and 2020) | 264,509 | 262,939 |
Inventories | 145,178 | 144,423 |
Prepaid expenses | 34,261 | 43,480 |
Total Current Assets | 1,694,529 | 1,696,124 |
Property, Plant and Equipment | ||
Equipment | 176,812 | 200,590 |
Leasehold improvements | 25,809 | 25,809 |
Property, Plant and Equipment, Gross, Ending Balance | 202,621 | 226,399 |
Less accumulated depreciation and amortization | (199,558) | (218,872) |
Total equipment and leasehold improvements net | 3,063 | 7,527 |
Operating Lease Right of Use | ||
Operating Lease Right of Use Asset | 96,570 | 193,140 |
Total Operating Lease Right of Use Asset | 96,570 | 193,140 |
Other Assets | ||
Patents less accumulated amortization | 91,415 | 105,058 |
Deposits | 5,937 | 5,937 |
Total other assets | 97,352 | 110,995 |
Assets, Total | 1,891,514 | 2,007,786 |
Current liabilities | ||
Accounts payable | 3,189 | 23,114 |
Accrued compensation and payroll taxes | 11,689 | 19,996 |
Other accrued liabilities | 543 | 434 |
Accrued vacation | 14,125 | 28,089 |
Operating lease liabilities | 97,980 | 95,160 |
Total current liabilities | 127,526 | 166,793 |
Long term liabilities | ||
Deferred income taxes | 24,992 | 19,812 |
Deferred income taxes | 24,992 | 19,812 |
Operating lease – long term | 97,980 | |
Total long term liabilities | 24,992 | 117,792 |
Stockholders' equity | ||
Common stock, no par value: 20,000,000 authorized shares Issued: 14,935,511 shares as of April 30, 2021 and 2020 | 660,988 | 660,988 |
Receivable from affiliate | (24,862) | (24,862) |
Retained earnings | 1,102,870 | 1,087,075 |
Total stockholders’ equity | 1,738,996 | 1,723,201 |
Liabilities and Equity, Total | $ 1,891,514 | $ 2,007,786 |
Balance Sheets (Parentheticals)
Balance Sheets (Parentheticals) - USD ($) $ / shares in Thousands | Apr. 30, 2021 | Apr. 30, 2020 |
Net of allowance for doubtful accounts | $ 500 | $ 500 |
Common stock, no par value (in dollars per share) | $ 0 | $ 0 |
Common stock, shares authorized (in shares) | 20,000,000 | 20,000,000 |
Common stock, shares issued (in shares) | 14,935,511 | 14,935,511 |
Statements of Income
Statements of Income - USD ($) | 12 Months Ended | |
Apr. 30, 2021 | Apr. 30, 2020 | |
Net sales | $ 1,173,143 | $ 1,237,393 |
Cost of sales | 433,979 | 439,533 |
Gross profit | 739,164 | 797,860 |
Operating expenses | ||
Marketing | 168,871 | 181,769 |
General and administrative | 394,918 | 402,261 |
Research and development | 157,919 | 164,358 |
Total operating expenses | 721,708 | 748,388 |
Income from operations | 17,456 | 49,472 |
Other income | ||
Interest income | 462 | 596 |
Other income | 11,420 | 1,920 |
Total other income | 11,882 | 2,516 |
Net income before income taxes | 29,338 | 51,988 |
Provision for income taxes | 13,543 | 15,940 |
Net income | $ 15,795 | $ 36,048 |
Net income per common share - basic and diluted (in dollars per share) | $ 0.001 | $ 0.002 |
Weighted-average shares of common stock outstanding - basic and diluted (in shares) | 14,935,511 | 14,935,511 |
Statements of Stockholders' Equ
Statements of Stockholders' Equity - USD ($) | Common Stock [Member] | Receivable from Affiliate [Member] | Retained Earnings [Member] | Total |
Balance (in shares) at Apr. 30, 2019 | 14,935,511 | |||
Balance at Apr. 30, 2019 | $ 660,988 | $ (19,699) | $ 1,051,027 | $ 1,692,316 |
Related Party Receivable | (5,163) | (5,163) | ||
Net Income | 36,048 | 36,048 | ||
Balance (in shares) at Apr. 30, 2020 | 14,935,511 | |||
Balance at Apr. 30, 2020 | $ 660,988 | (24,862) | 1,087,075 | 1,723,201 |
Net Income | 15,795 | 15,795 | ||
Balance (in shares) at Apr. 30, 2021 | 14,935,511 | |||
Balance at Apr. 30, 2021 | $ 660,988 | $ (24,862) | $ 1,102,870 | $ 1,738,996 |
Statements of Cash Flows
Statements of Cash Flows - USD ($) | 12 Months Ended | |
Apr. 30, 2021 | Apr. 30, 2020 | |
Cash flows from operating activities | ||
Net income | $ 15,795 | $ 36,048 |
Adjustments to reconcile net income to cash (used in) provided by operating activities | ||
Depreciation and amortization | 18,107 | 19,395 |
Noncash lease expense | 96,570 | 89,100 |
Deferred income taxes | 5,180 | (4,460) |
Gain on Sale of Equipment | (9,500) | |
Changes in assets and liabilities | ||
Accounts receivable | (1,570) | (16,576) |
Inventories, prepaid expenses and other | 8,464 | 32,433 |
Accounts payable and accrued expenses | (42,087) | 5,542 |
Building lease liability for right of use | (95,160) | (90,200) |
Total adjustments | (19,996) | 35,234 |
Net cash (used in) provided by operating activities | (4,201) | 71,282 |
Cash flow from investing activities | ||
Sale (Purchase) of equipment | 9,500 | (962) |
Related Party Receivable | (5,163) | |
Net cash provided by (used in) investing activities | 9,500 | (6,125) |
Increase in cash | 5,299 | 65,157 |
Cash beginning of year | 1,245,282 | 1,180,125 |
Cash end of year | 1,250,581 | 1,245,282 |
Supplemental disclosure of cash flow information | ||
Income taxes paid | 6,000 | |
Interest paid | ||
Right of Use Lease Asset and Liability | $ 193,140 |
Note 1 - Company Organization a
Note 1 - Company Organization and Description | 12 Months Ended |
Apr. 30, 2021 | |
Notes to Financial Statements | |
Business Description and Basis of Presentation [Text Block] | Note 1 Biosynergy, Inc. (the Company) was incorporated under the laws of the state of Illinois on February 9, 1976. R 90% April 30, 2021 92% April 30, 2020. |
Note 2 - Summary of Significant
Note 2 - Summary of Significant Accounting Policies | 12 Months Ended |
Apr. 30, 2021 | |
Notes to Financial Statements | |
Significant Accounting Policies [Text Block] | Note 2 Cash The Company maintains all of its cash in bank deposit accounts, which at times may No Receivables Receivables are carried at original invoice less estimates made for doubtful receivables. Management determines the allowance for doubtful accounts by reviewing and identifying troubled accounts on a periodic basis by using historical experience applied to an aging of accounts. A receivable is considered to be past due if any portion of the receivable balance is outstanding beyond the stipulated due date. Receivables are written off when deemed uncollectible. Recoveries of receivables previously written off are recorded when received. Inventories Inventories are valued using the FIFO ( first first Depreciation and Amortization Equipment and leasehold improvements are stated at cost. Depreciation is computed primarily using the straight-line method over the estimated useful lives of the respective assets. Repairs and maintenance are charged to expense as incurred. Renewals and betterments, which significantly extend the useful lives of existing equipment, are capitalized. Significant leasehold improvements are capitalized and amortized over ten three ten Prepaid Expenses Certain expenses, primarily insurance and income taxes, have been prepaid and will be used within one Revenue Recognition The Company accounts for revenue in accordance with ASU 2014 09, 606 2014 09 five The components as it relates to the Company are as follows: ● The Company's revenue is primarily generated from the sales of products directly to customers or through distribution channels, based on purchase orders and not ● ASU No. 2014 09 no Shipping and Handling Shipping and handling fees billed to customer, if any, are netted against the related costs which are included in cost of sales. The net cost is not Income Taxes Income taxes are provided for the tax effects of transactions reported in the financial statements and consist of taxes currently due and deferred taxes related primarily to differences in the methods of accounting for patents, inventories, certain accrued expenses and bad debt expenses for financial and income tax reporting purposes. The deferred income taxes represent the future tax consequences of those differences, which will be taxable in the future. See Note 4 The Company files tax returns in the U.S. federal jurisdiction and with the state of Illinois. Various tax years remain open to examinations, generally for three no not April 30, 2021. Leases The Company accounts for leases under ASC 842. Research and Development and Patents Research and development expenditures are charged to operations as incurred. The costs of obtaining patents, primarily legal fees, are capitalized and, once obtained, are amortized over the life of the respective patent using the straight-line method. Patents relate to products that have been developed and are being marketed by the Company. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Income Per Common Share Income per common share is computed by dividing net income by the weighted-average number of common shares outstanding during the period. Basic and diluted net income per common share is the same for the years ended April 30, 2021 2020 no Fair Value of Financial Instruments The Company evaluates its financial instruments based on current market interest rates relative to stated interest rates, length to maturity and the existence of readily determinable market prices. Based on the Company's analysis, the fair value of financial instruments recorded on the balance sheets as of April 30, 2021 2020, Segments Accounting standards have established annual reporting standards for an enterprise's operating segments and related disclosures about its products, services, geographic areas and major customers. The Company's operations were a single reportable segment and an international segment. The international segment operations are immaterial. Recent Accounting Pronouncements The FASB issues ASUs to amend the authoritative literature in Accounting Standards Certification (ASC). There have been a number of ASUs to date that amend the original text of ASCs. Except for the ASUs issued to date either (i) provide supplemental guidance, (ii) are technical corrections, (iii) are not not |
Note 3 - Inventories
Note 3 - Inventories | 12 Months Ended |
Apr. 30, 2021 | |
Notes to Financial Statements | |
Inventory Disclosure [Text Block] | Note 3 Inventories consist of the following: 2021 2020 Raw Materials $ 108,604 $ 106,284 Work-in-process 25,371 26,919 Finished goods 11,203 11,220 $ 145,178 $ 144,423 |
Note 4 - Income Taxes
Note 4 - Income Taxes | 12 Months Ended |
Apr. 30, 2021 | |
Notes to Financial Statements | |
Income Tax Disclosure [Text Block] | Note 4 The components of the deferred income tax (assets) and liabilities as of April 30, 2021 2020 2021 2020 Total deferred tax liabilities Patents $ 22,679 $ 26,227 Prepaid and other 6,274 6,458 Equipment and leaseholds 195 - 29,148 32,685 Total deferred tax assets Accrued vacation pay (4,003 ) (8,262 ) Equipment and leaseholds - (4,458 ) Other (153 ) (153 ) (4,156 ) (12,873 ) Net deferred income tax liabilities $ 24,992 $ 19,812 The provision for income taxes consists of the following components: 2021 2020 Current Federal $ 5,576 $ 13,601 State 2,787 6,799 8,363 20,400 Deferred 5,180 (4,460 ) $ 13,543 $ 15,940 The differences between the U.S. federal statutory tax rate and the Company's effective tax rate are as follows: Year ended April 30, 2021 2020 U.S. federal statutory tax rate 21.0 % 21.0 % State income tax expense, net of federal tax benefit 9.5 % 9.5 % Other 15.66 .1 Effective tax rate 46.16 % 30.6 % |
Note 5 - Related Party Transact
Note 5 - Related Party Transactions | 12 Months Ended |
Apr. 30, 2021 | |
Notes to Financial Statements | |
Related Party Transactions Disclosure [Text Block] | Note 5 The Company and its affiliates are related through common stock ownership as follows as of April 30, 2021: Stock of Affiliates Stock of Affiliates Biosynergy, Inc. F.K. Suzuki International, Inc. Medlab, Inc. F.K. Suzuki International, Inc. 30.0 % - % 100 % Fred K. Suzuki, Officer 4.1 30.0 - Jeanne S. Addis, as Trustee - 28.1 - Mary K. Friske, Officer 0.3 0.7 - Laurence C. Mead, Officer 0.4 10.0 - Beverly R. Suzuki 2.7 - - Lauane C. Addis, Officer - - - Malcolm MacCoun, Director - - - As of April 30, 2021 2020, $24,862 $5,163 2020 No A board member provides a variety of legal services to the Company in his capacity as a partner in a law firm. Fees for such legal services were $9,782 $11,579 April 30, 2021 2020, |
Note 6 - Lease Commitments
Note 6 - Lease Commitments | 12 Months Ended |
Apr. 30, 2021 | |
Notes to Financial Statements | |
Leases of Lessee Disclosure [Text Block] | Note 6 As a lessee, the Company will recognize lease assets and liabilities on the balance sheet for all arrangements with terms longer than 12 In February 2020, two May 1, 2020 April 30, 2022, two not two We have elected certain practical expedients available under the guidance, including a package of practical expedients which allows us to not not Maturities of lease liabilities as of April 30, 2021 Year Ending April 30: 2022 $ 97,980 Rent expense was $96,570 $89,100 April 30, 2021 2020, |
Note 7 - Customer Concentration
Note 7 - Customer Concentrations | 12 Months Ended |
Apr. 30, 2021 | |
Notes to Financial Statements | |
Concentration Risk Disclosure [Text Block] | Note 7 Shipments to one 32.9% 27.9% 2021 2020, April 30, 2021 2020, $96,930 $72,904, Shipments to another customer accounted for 36.7% 39.5% 2021 2020, April 30, 2021 2020, $134,682 $156,635, The Company had export sales of $53,670 $42,315 2020. not not The Company does not The Company is exposed to risks generally attendant to foreign operations, including but not not |
Note 8 - Employee Benefit Plan
Note 8 - Employee Benefit Plan | 12 Months Ended |
Apr. 30, 2021 | |
Notes to Financial Statements | |
Retirement Benefits [Text Block] | Note 8 Employee Benefit Plan The Company sponsors a 401 may April 30, 2021 2020 $29,521 $29,951, |
Note 9 - COVID-19 Pandemic and
Note 9 - COVID-19 Pandemic and Other | 12 Months Ended |
Apr. 30, 2021 | |
Notes to Financial Statements | |
Covid19 Pandemic [Text Block] | Note 9 COVID- 19 and Other The Company will face challenges in 2021 2022 19 three April 30, 2021 |
Significant Accounting Policies
Significant Accounting Policies (Policies) | 12 Months Ended |
Apr. 30, 2021 | |
Accounting Policies [Abstract] | |
Cash and Cash Equivalents, Policy [Policy Text Block] | Cash The Company maintains all of its cash in bank deposit accounts, which at times may No |
Receivable [Policy Text Block] | Receivables Receivables are carried at original invoice less estimates made for doubtful receivables. Management determines the allowance for doubtful accounts by reviewing and identifying troubled accounts on a periodic basis by using historical experience applied to an aging of accounts. A receivable is considered to be past due if any portion of the receivable balance is outstanding beyond the stipulated due date. Receivables are written off when deemed uncollectible. Recoveries of receivables previously written off are recorded when received. |
Inventory, Policy [Policy Text Block] | Inventories Inventories are valued using the FIFO ( first first |
Property, Plant and Equipment, Policy [Policy Text Block] | Depreciation and Amortization Equipment and leasehold improvements are stated at cost. Depreciation is computed primarily using the straight-line method over the estimated useful lives of the respective assets. Repairs and maintenance are charged to expense as incurred. Renewals and betterments, which significantly extend the useful lives of existing equipment, are capitalized. Significant leasehold improvements are capitalized and amortized over ten three ten |
Prepaid Expenses [Policy Text Block] | Prepaid Expenses Certain expenses, primarily insurance and income taxes, have been prepaid and will be used within one |
Revenue [Policy Text Block] | Revenue Recognition The Company accounts for revenue in accordance with ASU 2014 09, 606 2014 09 five The components as it relates to the Company are as follows: ● The Company's revenue is primarily generated from the sales of products directly to customers or through distribution channels, based on purchase orders and not ● ASU No. 2014 09 no |
Shipping and Handling Cost, Policy [Policy Text Block] | Shipping and Handling Shipping and handling fees billed to customer, if any, are netted against the related costs which are included in cost of sales. The net cost is not |
Income Tax, Policy [Policy Text Block] | Income Taxes Income taxes are provided for the tax effects of transactions reported in the financial statements and consist of taxes currently due and deferred taxes related primarily to differences in the methods of accounting for patents, inventories, certain accrued expenses and bad debt expenses for financial and income tax reporting purposes. The deferred income taxes represent the future tax consequences of those differences, which will be taxable in the future. See Note 4 The Company files tax returns in the U.S. federal jurisdiction and with the state of Illinois. Various tax years remain open to examinations, generally for three no not April 30, 2021. |
Lessee, Leases [Policy Text Block] | Leases The Company accounts for leases under ASC 842. |
Research and Development Expense, Policy [Policy Text Block] | Research and Development and Patents Research and development expenditures are charged to operations as incurred. The costs of obtaining patents, primarily legal fees, are capitalized and, once obtained, are amortized over the life of the respective patent using the straight-line method. Patents relate to products that have been developed and are being marketed by the Company. |
Use of Estimates, Policy [Policy Text Block] | Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. |
Earnings Per Share, Policy [Policy Text Block] | Income Per Common Share Income per common share is computed by dividing net income by the weighted-average number of common shares outstanding during the period. Basic and diluted net income per common share is the same for the years ended April 30, 2021 2020 no |
Fair Value of Financial Instruments, Policy [Policy Text Block] | Fair Value of Financial Instruments The Company evaluates its financial instruments based on current market interest rates relative to stated interest rates, length to maturity and the existence of readily determinable market prices. Based on the Company's analysis, the fair value of financial instruments recorded on the balance sheets as of April 30, 2021 2020, |
Segment Reporting, Policy [Policy Text Block] | Segments Accounting standards have established annual reporting standards for an enterprise's operating segments and related disclosures about its products, services, geographic areas and major customers. The Company's operations were a single reportable segment and an international segment. The international segment operations are immaterial. |
New Accounting Pronouncements, Policy [Policy Text Block] | Recent Accounting Pronouncements The FASB issues ASUs to amend the authoritative literature in Accounting Standards Certification (ASC). There have been a number of ASUs to date that amend the original text of ASCs. Except for the ASUs issued to date either (i) provide supplemental guidance, (ii) are technical corrections, (iii) are not not |
Note 3 - Inventories (Tables)
Note 3 - Inventories (Tables) | 12 Months Ended |
Apr. 30, 2021 | |
Notes Tables | |
Schedule of Inventory, Current [Table Text Block] | 2021 2020 Raw Materials $ 108,604 $ 106,284 Work-in-process 25,371 26,919 Finished goods 11,203 11,220 $ 145,178 $ 144,423 |
Note 4 - Income Taxes (Tables)
Note 4 - Income Taxes (Tables) | 12 Months Ended |
Apr. 30, 2021 | |
Notes Tables | |
Schedule of Deferred Tax Assets and Liabilities [Table Text Block] | 2021 2020 Total deferred tax liabilities Patents $ 22,679 $ 26,227 Prepaid and other 6,274 6,458 Equipment and leaseholds 195 - 29,148 32,685 Total deferred tax assets Accrued vacation pay (4,003 ) (8,262 ) Equipment and leaseholds - (4,458 ) Other (153 ) (153 ) (4,156 ) (12,873 ) Net deferred income tax liabilities $ 24,992 $ 19,812 |
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] | 2021 2020 Current Federal $ 5,576 $ 13,601 State 2,787 6,799 8,363 20,400 Deferred 5,180 (4,460 ) $ 13,543 $ 15,940 |
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] | Year ended April 30, 2021 2020 U.S. federal statutory tax rate 21.0 % 21.0 % State income tax expense, net of federal tax benefit 9.5 % 9.5 % Other 15.66 .1 Effective tax rate 46.16 % 30.6 % |
Note 5 - Related Party Transa_2
Note 5 - Related Party Transactions (Tables) | 12 Months Ended |
Apr. 30, 2021 | |
Notes Tables | |
Schedule of Stock Affiliates [Table Text Block] | Stock of Affiliates Biosynergy, Inc. F.K. Suzuki International, Inc. Medlab, Inc. F.K. Suzuki International, Inc. 30.0 % - % 100 % Fred K. Suzuki, Officer 4.1 30.0 - Jeanne S. Addis, as Trustee - 28.1 - Mary K. Friske, Officer 0.3 0.7 - Laurence C. Mead, Officer 0.4 10.0 - Beverly R. Suzuki 2.7 - - Lauane C. Addis, Officer - - - Malcolm MacCoun, Director - - - |
Note 6 - Lease Commitments (Tab
Note 6 - Lease Commitments (Tables) | 12 Months Ended |
Apr. 30, 2021 | |
Notes Tables | |
Lessee, Operating Lease, Liability, Maturity [Table Text Block] | Year Ending April 30: 2022 $ 97,980 |
Note 2 - Summary of Significa_2
Note 2 - Summary of Significant Accounting Policies (Details Textual) | 12 Months Ended |
Apr. 30, 2021 | |
Leasehold Improvements [Member] | |
Property, Plant and Equipment, Useful Life (Year) | 10 years |
Equipment [Member] | Minimum [Member] | |
Property, Plant and Equipment, Useful Life (Year) | 3 years |
Equipment [Member] | Maximum [Member] | |
Property, Plant and Equipment, Useful Life (Year) | 10 years |
Note 3 - Inventories - Schedule
Note 3 - Inventories - Schedule of Inventory (Details) - USD ($) | Apr. 30, 2021 | Apr. 30, 2020 |
Raw Materials | $ 108,604 | $ 106,284 |
Work-in-process | 25,371 | 26,919 |
Finished goods | 11,203 | 11,220 |
Inventory, Gross, Total | $ 145,178 | $ 144,423 |
Note 4 - Income Taxes - Schedul
Note 4 - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($) | Apr. 30, 2021 | Apr. 30, 2020 |
Patents | $ 22,679 | $ 26,227 |
Prepaid and other | 6,274 | 6,458 |
Equipment and leaseholds | 195 | |
Deferred Tax Liabilities, Net, Total | 29,148 | 32,685 |
Accrued vacation pay | (4,003) | (8,262) |
Equipment and leaseholds | (4,458) | |
Other | (153) | (153) |
Deferred Tax Assets, Net of Valuation Allowance, Total | (4,156) | (12,873) |
Net deferred income tax liabilities | $ 24,992 | $ 19,812 |
Note 4 - Income Taxes - Compone
Note 4 - Income Taxes - Components of Income Tax Expense Benefit (Details) - USD ($) | 12 Months Ended | |
Apr. 30, 2021 | Apr. 30, 2020 | |
Federal | $ 5,576 | $ 13,601 |
State | 2,787 | 6,799 |
Current Income Tax Expense (Benefit), Total | 8,363 | 20,400 |
Deferred | 5,180 | (4,460) |
Income Tax Expense (Benefit), Total | $ 13,543 | $ 15,940 |
Note 4 - Income Taxes - Effecti
Note 4 - Income Taxes - Effective Income Tax Rate Reconciliation (Details) | 12 Months Ended | |
Apr. 30, 2021 | Apr. 30, 2020 | |
U.S. federal statutory tax rate | 21.00% | 21.00% |
State income tax expense, net of federal tax benefit | 9.50% | 9.50% |
Other | 15.66% | 0.10% |
Effective tax rate | 46.16% | 30.60% |
Note 5 - Related Party Transa_3
Note 5 - Related Party Transactions (Details Textual) - USD ($) | 12 Months Ended | |
Apr. 30, 2021 | Apr. 30, 2020 | |
Due from Affiliate, Noncurrent | $ 24,862 | $ 24,862 |
F. K. Suzuki International, Inc. [Member] | ||
Due from Affiliate, Noncurrent | 24,862 | 24,862 |
F. K. Suzuki International, Inc. [Member] | Corporate Compliance Costs [Member] | ||
Related Party Transaction, Amounts of Transaction | 5,163 | |
Board Member [Member] | Legal Fees [Member] | ||
Related Party Transaction, Expenses from Transactions with Related Party | $ 9,782 | $ 11,579 |
Note 5 - Related Party Transa_4
Note 5 - Related Party Transactions - Schedule of Stock Affiliates (Details) | Apr. 30, 2021 |
Biosynergy, Inc. [Member] | F. K. Suzuki International, Inc. [Member] | |
Ownership percentage | 30.00% |
Biosynergy, Inc. [Member] | Fred K. Suzuki, Officer [Member] | |
Ownership percentage | 4.10% |
Biosynergy, Inc. [Member] | Jeanne S. Addis, Trustee [Member] | |
Ownership percentage | |
Biosynergy, Inc. [Member] | Mary K. Friske, Officer [Member] | |
Ownership percentage | 0.30% |
Biosynergy, Inc. [Member] | Laurence C. Mead, Officer [Member] | |
Ownership percentage | 0.40% |
Biosynergy, Inc. [Member] | Beverly R. Suzuki [Member] | |
Ownership percentage | 2.70% |
Biosynergy, Inc. [Member] | Lauane C. Addis, Officer [Member] | |
Ownership percentage | |
Biosynergy, Inc. [Member] | Malcom MacCoun, Director [Member] | |
Ownership percentage | |
F. K. Suzuki International, Inc. [Member] | F. K. Suzuki International, Inc. [Member] | |
Ownership percentage | |
F. K. Suzuki International, Inc. [Member] | Fred K. Suzuki, Officer [Member] | |
Ownership percentage | 30.00% |
F. K. Suzuki International, Inc. [Member] | Jeanne S. Addis, Trustee [Member] | |
Ownership percentage | 28.10% |
F. K. Suzuki International, Inc. [Member] | Mary K. Friske, Officer [Member] | |
Ownership percentage | 0.70% |
F. K. Suzuki International, Inc. [Member] | Laurence C. Mead, Officer [Member] | |
Ownership percentage | 10.00% |
F. K. Suzuki International, Inc. [Member] | Beverly R. Suzuki [Member] | |
Ownership percentage | |
F. K. Suzuki International, Inc. [Member] | Lauane C. Addis, Officer [Member] | |
Ownership percentage | |
F. K. Suzuki International, Inc. [Member] | Malcom MacCoun, Director [Member] | |
Ownership percentage | |
Medlab, Inc. [Member] | F. K. Suzuki International, Inc. [Member] | |
Ownership percentage | 100.00% |
Medlab, Inc. [Member] | Fred K. Suzuki, Officer [Member] | |
Ownership percentage | |
Medlab, Inc. [Member] | Jeanne S. Addis, Trustee [Member] | |
Ownership percentage | |
Medlab, Inc. [Member] | Mary K. Friske, Officer [Member] | |
Ownership percentage | |
Medlab, Inc. [Member] | Laurence C. Mead, Officer [Member] | |
Ownership percentage | |
Medlab, Inc. [Member] | Beverly R. Suzuki [Member] | |
Ownership percentage | |
Medlab, Inc. [Member] | Lauane C. Addis, Officer [Member] | |
Ownership percentage | |
Medlab, Inc. [Member] | Malcom MacCoun, Director [Member] | |
Ownership percentage |
Note 6 - Lease Commitments (Det
Note 6 - Lease Commitments (Details Textual) - USD ($) | 12 Months Ended | ||
Apr. 30, 2021 | Apr. 30, 2020 | Feb. 28, 2020 | |
Lessee, Operating Lease, Term of Contract (Year) | 2 years | ||
Operating Lease, Expense | $ 96,570 | $ 89,100 |
Note 6 - Lease Commitments - Op
Note 6 - Lease Commitments - Operating Lease Liability Maturity (Details) | Apr. 30, 2021USD ($) |
Label | $ 97,980 |
Note 7 - Customer Concentrati_2
Note 7 - Customer Concentrations (Details Textual) | 12 Months Ended | |
Apr. 30, 2021USD ($) | Apr. 30, 2020USD ($) | |
Export Sales | $ 53,670 | $ 42,315 |
Customer One[Member] | ||
Accounts Receivable, before Allowance for Credit Loss | 96,930 | 72,904 |
Customer Two [Member] | ||
Accounts Receivable, before Allowance for Credit Loss | $ 134,682 | $ 156,635 |
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | ||
Number of Customers | 1 | 1 |
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer One[Member] | ||
Concentration Risk, Percentage | 32.90% | 27.90% |
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer Two [Member] | ||
Concentration Risk, Percentage | 36.70% | 39.50% |
Note 8 - Employee Benefit Plan
Note 8 - Employee Benefit Plan (Details Textual) - USD ($) | 12 Months Ended | |
Apr. 30, 2021 | Apr. 30, 2020 | |
Defined Contribution Plan, Employer Discretionary Contribution Amount | $ 29,521 | $ 29,951 |
Note 9 - COVID-19 Pandemic an_2
Note 9 - COVID-19 Pandemic and Other (Details Textual) | 3 Months Ended |
Jul. 29, 2021 | |
Subsequent Event [Member] | |
Number of Employees Resigned | 3 |